Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Axiomedic appears to have been a small private healthcare company focused broadly on discovering, developing, manufacturing, and marketing medical devices and medicines for unmet medical needs. Publicly available information is sparse and does not show a clearly disclosed clinical pipeline, named lead assets, or validated therapeutic targets. Multiple business-directory sources describe the company as active historically, but Israeli registry information indicates the core Israeli entity, AXIOMEDIC - ADVANCED MEDICAL SOLUTIONS LTD, was voluntarily liquidated, suggesting the business is no longer operating as an active biotech/pharma developer. An affiliated U.S. entity, Axiomedic USA LLC, has been listed in New York business records, but there is not enough evidence to conclude it supports an active operating pipeline. Overall, Axiomedic should be treated as a defunct or inactive small healthcare company with limited public disclosure.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Axiomedic.